Coronavirus Actions: How Pharma In India Is Handling Safety, Business Continuity

It’s a complex balance - ensuring both the health and safety of employees across operations and uninterrupted availability of medicines - as the coronavirus pandemic ravages countries large and small. The pharma industry in India, like elsewhere, is using a mix of efforts, ranging from the standard work from home advisories and putting digital technology to use to daily temperature checks at sites, to manage business continuity. 

The common thread across companies is that the health and safety of employees and their families is the core priority, and broadly speaking medical representative (MR) calls appear to be one of the most curtailed activities